Moderna, Merck’s skin cancer vaccine shows rise in survival rates
Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or.
Drugs
Health
Pharma
Drugs
Medical
Pharma
Merck discontinues trial for combo cancer drug for melanoma
HQ Team May 13, 2024: Merck has discontinued another cancer experimental immunotherapy treatment in patients with a severe form of melanoma due to.
Drugs
Health
Pharma
New drug to fight skin cancer gets nod from US drug regulator
HQ Team February 17, 2024: Iovance Biotherapeutics, a San Carlos, California-based company, has been given the nod for its T-cell therapy to treat.
Drugs
Medical
Pharma
FDA green lights DermaSensor’s skin cancer detection device in the US
HQ Team January 18, 2024: The FDA has approved US-based DermaSensor Inc.’s handheld wireless skin cancer detection device that is powered by artificial.
Drugs
Medical
Pharma
Moderna’s melanoma vaccine shows promise in clinical trials
HQ Team December 23, 2023: Moderna unveiled a skin cancer vaccine that demonstrated promising results in recent clinical trials. The vaccine, administered in.
Drugs
Pharma
Merck pays Moderna $250m for joint development of skin cancer vaccine
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma
Drugs
Medical
Innovative Liquid Radiotherapy for Skin Cancer under Trial
Liquid radiotherapy used as an alternative to surgical removal of cancerous lesions